Nanobiotechnology
| Product Code | GIA01411 |
| Publication Date | February 2011 |
| Publisher | Global Industry Analysts |
| Product Type | Report |
| Pages | 642 |
| ISBN Number | not applicable |
Nanobiotechnology
This report analyzes the worldwide markets for Nanobiotechnology in US$ Million by the following technology segments - Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, & Other Nanomaterials), and Nanodevices/Tools. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players worldwide such as Aduro BioTech, Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Unidym, Inc., Agilent Technologies Inc., Asklepios BioPharmaceutical Inc., Biosante Phosphate Pharmaceuticals, Inc., Celgene Corporation, Abraxis Bioscience, Inc., Elan Pharmaceuticals, Flamel Technologies, Inc., Gilead Sciences Inc., Life Technologies Corporation, BioTrove, Inc., NanoBio Corporation, Nanogen, Inc., Nanophase Technologies Corporation, pSivida Ltd., Sigma Aldrich Company, Starpharma Holdings Ltd., Dendritic Nanotechnologies, Inc., SkyePharma Pharmaceuticals, Unidym, Inc., and Zyvex Instruments LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
- 1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- 1. Nanomaterials
- Solid Inorganic Nanoparticles
- Nanocomposites
- Nanostructured Materials and Membranes
- Nanotubes and Fullerenes
- Other Nanomaterials
- Nanoshells
- Nanohorns
- Nanocapsules
- 2. Nanodevices/Tools
- 2.INDUSTRY OVERVIEW
- A Curtain Raiser
- Nanobiotechnology - The Next Big Thing
- Nanotechnology & Biology Tie the Knot: "Two to Tango"
- Where Conventional Molecular Science Falls Short... Nanobio Steps In
- What's The Obsession With Size?
- Why Analysis at the Cellular Level is Important?
- Lessons from Nature
- Dawn Breaks On Nanobiotechnology
- Demystifying the Intriguing World of Nanobiotech
- A Meeting Place of Medicine's Best Solutions
- Nanobiotechnology Promises to Deliver Nanomedicine
- Nanobiotechnology to Become Viable for All Drug Development Stages
- Nanobioproducts in R&D As of 2007 & 2008
- List of Marketed Nanoparticle-Based Pharmaceutical Products As of the Year 2007
- Nanoparticles: The Foundation of Nanobiotechnology
- Improved Optical Properties and Stability of Nanoparticles
- Nanoemulsions
- Diagnosis & Treatment of Cancer
- The Promise of Nanobiotechnology
- Biological Weaponries Against Diseases Come in Small Packages
- Proffered Benefits of Nanobiotechnology
- Opportunity & Beyond
- Nanobiotechnology - Will it Live Up to the Expectations?
- The Future of Nanobiotechnology: Shape of Things to Come
- Nanobiotechnology: The Outer Limits
- Futuristics: A Rumination
- Nanobiotechnology In the Year 2015
- Field of Nanodiagnostics
- Field of Regenerative Medicine
- Field of Targeted Drug Delivery
- Conclusions
- 3.MARKET DYNAMICS
- Nanotechnology in the Recent Economic Climate: A Review
- Nanobio Feels the Pinch or Does It...?: A Closer Look
- Outlook
- Developing Countries to Rise Over the Horizon
- Nanomaterials & Nanoparticles Witness Robust Activity
- Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
- Private & Public Companies to Step Up Funding on Nanotechnology
- Increasing Awareness on Technology to Drive Growth
- Demand for Novel Products to Push Up Growth
- Nano-Enabled Drug Discovery Holds Tremendous Potential
- Consolidation Sharpens the Industry's Edge
- The Regulatory Framework Evolves with the Technology
- Quantum Dot Patents Pose Legal Tangles
- Miniaturized Liquid Handling Becomes Progressive
- Trends in Nanotechnology Enabled Drug Delivery Systems
- Robust Growth On Cards
- Patent Expiries: A Key Driver
- Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs
- 4.INDUSTRY CHALLENGES & ISSUES
- Challenges
- Commercial Exploration: A Treacherous Voyage
- Conventional Medicine to Contest Nanomedicine Adoption
- Nanomaterials Use: Weighed Down with Toxicity Concerns
- Production Issues Continue to Plague Nanobiotech Industry
- Lack of De Facto Standards: A Challenge to Reckon With
- Embroilment Over Ethical Issues
- Social Relevance
- Economic Relevance
- 5.INDUSTRY STRUCTURE
- Industry Structure: A Quick Primer
- A Dissection of Select Segments
- Nanoparticles
- Nanotubes and Fullerenes
- Dendrimers
- A Peek Into the Regulatory Framework
- United States
- Europe
- A Closer Look at Regional Nano Efforts
- United States: Unraveling the Country's Edge
- Europe: Hot On the Heels of the US
- Germany
- France
- United Kingdom
- Scandinavia
- Japan: A Noteworthy Region
- 6.NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE
- A Primer
- Impact on Drug Delivery Systems
- Benefits Offered
- Drug Encapsulation
- High Level of Specificity
- Increase in Drug Solubility and Uptake
- Greater Usage Flexibility
- Impact On Molecular Diagnostic Imaging
- Seeing The Unseen
- Impact On Pharmaceutical Drug Formulations
- Impact On Therapeutics
- Silver Nanoparticles as Effective Antimicrobial Agents
- Modern Day Nanomedicine: A Current Scenario
- Nanomedicine: The Cynosure of All Eyes
- Drug Delivery Systems Epitomized by Nanomedicine
- Targeted NanoDrug Delivery & Release
- Active and Passive Targeting Mechanisms in Drug Delivery
- Sustained and Pulsatile Release Mechanisms in Drug Delivery
- A Peek Into Potential Nanobio Enabled Drug Carriers
- Micelles
- Liposomes
- Dendrimers & Liquid Crystals
- Nanoparticles
- Polymeric Nanoparticles
- Hydrogels
- Molecularly Imprinted Polymers
- Microelectromechanical Systems (MEMS)
- Nanosuspensions
- Fullerenes: A Platform for GenX Drug Delivery
- Types of Nano-Based Drug Delivery Systems, Related Materials, and Structures
- Dynamics of Regenerative Medicine
- Tissue Engineering and Restorations
- Nanotechnology Enabled Diagnostics
- Promised Path Breaking Applications in Molecular Diagnostics & Imaging
- In-Vitro Diagnostics
- Nanoprobes & Implantable Devices in In-vivo Imaging
- Nanocomposites in Molecular Labeling & Diagnostics
- Laboratory-on-a-Chip - A Revolutionary Technology in Biomolecular Detection
- Biosensors - Heralding New Opportunities in Molecular Diagnostics
- Nanobiosensors - A New Approach to Diagnostics Testing
- Despite Huge Potential ... Key Hurdles Remain in Commercialization
- Magnetic Nanoparticles for Imaging Applications in MRI
- Dendrimers Promise Milestone Applications in MRI
- Conclusions
- Gauging the Real World Impact of Nanobiotech On Cancer: A Case Study
- Quantum Dots Cock a Snook at Traditional Anti-Body Labeling Agents
- Chemotherapeutic Reengineering & Gene Therapy: New Treatment Regimes
- Laboratory-on-chip (LOC): A Platform for Cancer Diagnosis
- 7.CONCEPTUAL OVERVIEW
- Nanotechnology: An Introduction
- A Revolution in the Making
- Nanobiotechnology: An Exposition
- Nanobiotechnology & Medicine
- Nanobiotechnology & Biofuels
- Global Nanobiotechnology Market (2005): Major Products
- Global Nanobiotechnology Market (2005): Major Products Under Development
- Analysis of Major Technology Segments
- Nanomaterials
- Nanoparticles
- Nanoparticles in Labeling or Bio Tagging
- Nanoparticles as Biomarkers
- Classification of Nanoparticles
- Solid Nanoparticles
- Solid Lipid Nanoparticles
- Calcium Phosphate Nanoparticles
- Dendrimers
- Nanocomposites
- Lamellar Nanocomposites
- Nanostructured Materials and Membranes
- Nanotubes and Fullerenes
- Other Nanomaterials
- Nanoshells
- Nanohorns
- Nanocapsules
- Nanodevices
- Nanotools
- Select Nanotools
- Atomic Force Microscopes
- Hot Embossing Lithography
- Dip-Pen Nanolithography
- 8.GLOBAL RESEARCH CENTERS AND INSTITUTIONS
- Centre for Biologic Nanotechnology (USA)
- Centre for Biological and Environmental Nanotechnology (USA)
- Institute of Bioengineering and Nanotechnology (Singapore)
- The Nanobiotechnology Center (USA)
- The Tyndall National Institute (Ireland)
- 9.RECENT INDUSTRY ACTIVITY/PRODUCT LAUNCHES
- IDEX Inks Deal to Acquire Microfluidics
- NanoMech Takes Over Canano
- Arrowhead Sells Unidym to Wisepower
- MP Biomedicals Signs Agreement of Cooperation with Russian Nanotechnology Corporation
- Bruker Acquires AFM and OIM Segments from Veeco
- Audax Inks an Agreement with Brown to Acquire Osteobiologic Nanotechnology
- Celgene Acquires Abraxis
- ELITech Completes Assets Acquisition of Nanogen
- Life Technologies Acquires BioTrove
- GSK Inks License With NanoBio to Market NB-001
- CPN Establishes New Medical Nanobiotechnology R&D Center
- IBM to Setup New Research Center in Wroclaw
- Life Technologies and Zymera Ink Licensing Deal for Quantum Dots Technology
- APR Acquires Nanotechnology Platform Technology for Preparing Biotechnology Products
- Lockheed Teams Up with IIT-Delhi for Nanobiotechnology Research
- Piedmont Triad to Institute Statewide Nanobiotech Center
- Biocon and Abraxis Introduce ABRAXANE in India
- Starpharma Launches a Research Reagent Kit
- Monash Enters Into a Deal with National Fabrication Facility of Australia
- Taiwan Inks Nanotechnology Collaboration Deal with Australia
- Avanti Institutes New Targeted Drug Delivery Company, Chikujee Therapeutics
- CytoViva Rolls Out New Research Tool for Nanotechnology
- Dabur Obtains DCGI Approval for Nanoxel in New Indications
- Researchers Discover New Nanoparticles for Treating Brain Infection
- Capsulution Tests Nanoparticle-Based Drug Formulation for Improved Bio-Availability
- Invitrogen Signs Agreement with Genisphere
- Sigma-Aldrich Signs Deal With Nanoco Technologies
- Unidym Sells First License Option for Patent Portfolio to MDA
- Unidym Spins Off Carbon Nanotubes Therapeutics Business into Ensysce Biosciences
- Nacalai USA and Nano-C Enter into Collaboration Agreement for HPLC Technology
- Advanced Materials Technology Obtains License for LBL® Technology from Capsulution
- Nanogen and The Elitech Group Announce Merger
- NanoViricides Signs MCRADA Agreement with CDC for Rabies
- Manhattan Scientifics Acquires Metallicum
- HemCon Medical Technologies Acquires Alltracel Pharmaceuticals
- CN Probes Inks Agreement With a Leading MEMS Foundry
- PrimeGen Biotech LLC Enters into Corporate Alliance with Unidym
- Ondine Acquires Exclusive License from UCL Business
- Dabur Introduces Nanotechnology Based Anti-Cancer Drug Delivery System - Nanoxel
- Mitsui Ties Up With NIOSH to Evaluate Safety of Carbon Nanotubes
- Unidym Merges with Carbon Nanotechnologies
- 10.FOCUS ON SELECT GLOBAL PLAYERS
- Aduro BioTech (USA)
- Arrowhead Research Corporation (USA)
- Calando Pharmaceuticals, Inc. (USA)
- Agilent Technologies Inc (USA)
- Asklepios BioPharmaceutical Inc (USA)
- Biosante Phosphate Pharmaceuticals, Inc. (USA)
- Celgene Corporation (USA)
- Abraxis Bioscience, Inc (USA)
- Elan Pharmaceuticals, Inc. (USA)
- Flamel Technologies, Inc. (France)
- Gilead Sciences Inc (USA)
- Life Technologies Corporation (USA)
- BioTrove, Inc. (USA)
- NanoBio Corporation (USA)
- Nanogen, Inc. (US)
- Nanophase Technologies Corporation (USA)
- pSivida Ltd (Australia)
- Sigma Aldrich Company (USA)
- Starpharma Holdings Ltd. (Australia)
- Dendritic Nanotechnologies, Inc. (USA)
- SkyePharma Pharmaceuticals (UK)
- Unidym, Inc. (USA)
- Zyvex Instruments LLC (USA)
- 11.GLOBAL MARKET PERSPECTIVE
- Analytics by Product Segment
- Analytics by Application
- 12.THE UNITED STATES
- A. Market Analysis
- Outlook
- Industry Overview
- Public Sector Funding
- Major Nanobiotechnology Institutions and Centers
- The Nanobiotechnology Center (NBTC)
- Key technological advances achieved by NBTC in recent years -
- Principal NBTC Partners
- Centre for Biologic Nanotechnology (CBN)
- Centre for Biological and Environmental Nanotechnology (CBEN)
- Regulatory Environment
- B. Market Analytics
- 13.JAPAN
- A. Market Analysis
- Public Sector Funding
- B. Market Analytics
- 14.EUROPE
- A. Market Analysis
- Outlook
- Market Overview
- European Union Banks Heavily on Nanobiotechnology
- Nano2Life Network
- Major Nanobiotechnology Networks in Europe as of the Year 2006
- Public Sector Funding
- Regulatory Environment
- Registration for Novel Nanobiotech Drugs Pose Major Bottlenecks
- Focus on Select Markets
- Germany
- France
- United Kingdom
- Russia
- Russian Biotech Players Eye Partnerships with Indian Counterparts
- Rest of Europe
- Ireland
- Market Overview
- Key Research Institutions/Centers in Nanobiotechnology
- The Tyndall National Institute
- The Centre for Research on Adaptive Nanostructures and NanoDevices
- The National Centre for Sensor Research
- The Sami Nasr Institute for Advanced Materials Science
- B. Market Analytics
- 15.REST OF WORLD
- A. Market Analysis
- Outlook
- Public Sector Funding
- Focus on Select Markets
- Australia
- Market Overview
- Major Institutions
- Commonwealth Scientific and Industrial Research Organisation (CSIRO)
- India
- Market Overview
- Government Takes Big Initiatives to Promote Nanobiotechnology
- Agriculture, Livestock Sectors to Warm Up to Nanobiotechnology Benefits
- Korea
- Taiwan
- Nanotechnology in Medicine - Small Yet Growing Segment in Taiwan
- Iran
- B. Market Analytics
- Total Companies Profiled: 117 (including Divisions/Subsidiaries - 122)
- Region/CountryPlayers
- The United States
- Canada
- Japan
- Europe
- France
- Germany
- The United Kingdom
- Rest of Europe
- Asia-Pacific (Excluding Japan)
- Middle-East